Stability Indicating RP-HPLC Method for Quantification of Sarecycline and Its Impurities in Sarecycline Solid Dosage Form

Authors

  • P. Venkata Prabhakara Rao Department of Chemistry, University College of Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, India
  • Syed Mastan Ali Department of Chemistry, University College of Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, India.
  • P. Bharath Department of Chemistry, University College of Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, India.
  • D. Ramachandran Department of Chemistry, University College of Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, India.

DOI:

https://doi.org/10.5530/ctbp.2023.4.82

Keywords:

Sarecycline, Liquid chromatography, Related substances, Assay, Forced degradation and Validation

Abstract

The primary objective of the research work is to develop an effective, sensitive, eco- nomical and simple reverse phase HPLC meth- od for quantification of Sarecycline and its impu- rities in Sarecycline parenteral dosage form. The separation was achieved by using a sta- tionary phase water X-Bridge shield RP18 (150 x 4.6 mm, 3.5µ) and the mobile phase consists of ammonium acetate buffer and acetonitrile in the proportion of gradient elution. The flow rate was 1.0 mL/min. Sarecycline was detected by using UV detector at the wavelength of 240 nm. The column temperature was maintained at 40°C and sample cooler temperature was main- tained at 5°C, injection volume 10µL, run time was 45 minutes. The developed method was validated for various parameters as per ICH guidelines like accuracy, precision, linearity, specificity, solution stability

Linearity graph of Sarecycline

Downloads

Published

08-12-2023

How to Cite

Rao, P. V. P., Ali, S. M., Bharath, P. ., & Ramachandran, D. . (2023). Stability Indicating RP-HPLC Method for Quantification of Sarecycline and Its Impurities in Sarecycline Solid Dosage Form. Current Trends in Biotechnology and Pharmacy, 17(4), 1486–1495. https://doi.org/10.5530/ctbp.2023.4.82